OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
Meng-Ping Xi, Shanshan Guo, Caicike Bayin, et al.
Frontiers of Medicine (2021) Vol. 16, Iss. 3, pp. 442-458
Open Access | Times Cited: 14
Meng-Ping Xi, Shanshan Guo, Caicike Bayin, et al.
Frontiers of Medicine (2021) Vol. 16, Iss. 3, pp. 442-458
Open Access | Times Cited: 14
Showing 14 citing articles:
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 12
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 12
QRICH1 suppresses pediatric T-cell acute lymphoblastic leukemia by inhibiting GRP78
Jiou Zhao, Meiyun Kang, Huimin Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 5
Jiou Zhao, Meiyun Kang, Huimin Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 5
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy
Han‐Yu Cao, Ling Li, Shengli Xue, et al.
Hematological Oncology (2022) Vol. 41, Iss. 3, pp. 301-309
Open Access | Times Cited: 21
Han‐Yu Cao, Ling Li, Shengli Xue, et al.
Hematological Oncology (2022) Vol. 41, Iss. 3, pp. 301-309
Open Access | Times Cited: 21
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma
Yuan-hong Huang, Chao‐Ling Wan, Haiping Dai, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2001-2013
Closed Access | Times Cited: 12
Yuan-hong Huang, Chao‐Ling Wan, Haiping Dai, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2001-2013
Closed Access | Times Cited: 12
HDAC inhibitors: Promising agents for leukemia treatment
Yun Deng, Cheng Qian, Jing He
Biochemical and Biophysical Research Communications (2023) Vol. 680, pp. 61-72
Closed Access | Times Cited: 11
Yun Deng, Cheng Qian, Jing He
Biochemical and Biophysical Research Communications (2023) Vol. 680, pp. 61-72
Closed Access | Times Cited: 11
Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
Yingjun Zhang, Ge Zhang, Yuefang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Yingjun Zhang, Ge Zhang, Yuefang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control
Xianzhe Huang, Wenwei Chen, Yanyan Wang, et al.
Frontiers of Medicine (2025)
Closed Access
Xianzhe Huang, Wenwei Chen, Yanyan Wang, et al.
Frontiers of Medicine (2025)
Closed Access
Novel therapies for pediatric acute lymphoblastic leukemia
Zachary Graff, Michael J. Burke, Nathan Gossai
Current Opinion in Pediatrics (2023) Vol. 36, Iss. 1, pp. 64-70
Closed Access | Times Cited: 4
Zachary Graff, Michael J. Burke, Nathan Gossai
Current Opinion in Pediatrics (2023) Vol. 36, Iss. 1, pp. 64-70
Closed Access | Times Cited: 4
A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL
Xueying Wang, Yan Deng, Guangcui He, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Xueying Wang, Yan Deng, Guangcui He, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial
Jieping Lin, Zicong Huang, Zihong Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Jieping Lin, Zicong Huang, Zihong Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Tracking intracellular nuclear targeted-chemotherapy of chidamide-loaded Prussian blue nanocarriers by SERS mapping
Xinyue Xing, Wanqing Zhong, Ping Tang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 229, pp. 113469-113469
Closed Access | Times Cited: 3
Xinyue Xing, Wanqing Zhong, Ping Tang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 229, pp. 113469-113469
Closed Access | Times Cited: 3
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.
Xuanqi Cao, Zheng Li, Yanming Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Xuanqi Cao, Zheng Li, Yanming Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Metformin and chidamide synergistically suppress multiple myeloma progression and enhance lenalidomide/bortezomib sensitivity
Jianping Mao, Ran Chen, Lianguo Xue, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 4, pp. 2452-2465
Closed Access
Jianping Mao, Ran Chen, Lianguo Xue, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 4, pp. 2452-2465
Closed Access
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation
Xuanqi Cao, Zheng Li, Yanming Zhang, et al.
Annals of Hematology (2024)
Open Access
Xuanqi Cao, Zheng Li, Yanming Zhang, et al.
Annals of Hematology (2024)
Open Access
